Mobileye reported Q1 2026 revenue of $558M (+27% YoY) against guidance of approximately +19%, raised full-year 2026 guidance to $1.975B at the midpoint, and announced its first-ever share buyback program framed as offsetting dilution from the Menti acquisition. Four signals upgraded, zero deteriorated. The paradox: the stock declined roughly 18% to $8.70 between the prior analysis and the print, driven partly by a $3.8B non-cash goodwill impairment that is a mechanical accounting consequence of the price decline rather than operational deterioration. Valuation compressed to ~3.5x revenue while fundamentals materially improved. Thesis classification moved from price-at-value to undervalued.
Q1 2026 Numbers vs Guidance
| Metric | Q1 2026 Actual | Prior Guide |
|---|---|---|
| Revenue | $558M (+27% YoY) | ~+19% YoY ($519M implied) |
| Adj. operating income | $95M (+61% YoY) | In line |
| Adj. operating margin | 17% | ~13% Q1 2025 |
| Operating cash flow | $75M | Despite working capital drag |
| FY2026 revenue guide (raised) | $1.975B midpoint (+4% YoY) | ~$1.9B (flat-to-+5%) |
| FY2026 adj. op. income guide (raised) | $210M midpoint | $195M midpoint |
| Goodwill impairment (non-cash) | $3.8B | — |
Three Concurrent Demand Drivers
Management identified three distinct tailwinds behind the beat, each with different durability profiles:
- China OEM export volume — roughly half of the Q1 upside. Mobileye has higher share in Chinese OEM export vehicles than domestic ones. Those export vehicles are going to emerging markets (Asia, South America) where Mobileye had no prior exposure. CEO Shashua characterized this as a “net gain, not cannibalization” of European or American business.
- ADAS fitment rate increases at top-10 Western customers — organic content growth that management described as “constant demand throughout the year.”
- Safety stock normalization — Tier 1 supplier inventory rebuilt from under three weeks (at end of 2025) to four-to-five weeks (“normal”). Management: “We do not anticipate this volume to reverse this year.”
The full-year raise only captures the Q1 beat. Management explicitly left H2 2026 conservatism intact, citing uncertainty about whether the China export strength sustains. Q2 is guided to $558M in Q1 context but -6% YoY on a tough comparison — a calendar effect, not a slowdown signal.
Surround ADAS: From Narrative to Contract
The most structurally important disclosure was the Surround ADAS update. At the prior analysis, Mobileye had one announced design win (VW Group, 2028 SOP). Q1 brought the total to three:
- Volkswagen Group — entire entry-fleet upgrade starting 2028
- Major US EV OEM (announced at CES 2026) — entire EV fleet at a higher ASP than VW
- Mahindra — first Indian OEM on Surround ADAS, unlocking a market where regulation in 2027 is expected to drive ADAS penetration from ~8% to 70-90% in two-to-three years
Management quantified unit economics that were previously undisclosed: $100-150 ASP (vs $40-50 for base ADAS) with ~70% gross margin. Nehushtan’s summary: “In just a year to have three design wins, two out of the top-10 OEMs with significant volumes — this in and of itself, without new design wins, can represent more than a 10% increase in revenue on a yearly basis” when the programs launch.
VW Reaffirmation and Porsche US Test
EVP of Business Development Nimrod Nehushtan addressed recent market speculation about a potential VW strategy shift with unusually direct language: “All of the upcoming SOPs, product launches across all brands of Volkswagen Group, spanning from base ADAS in lower-priced vehicles to robotaxi and everything in between — of the upcoming SOPs are with Mobileye Global Inc. products. This is the plan of record. It has been the plan of record in the past couple of years, and it did not change. If anything, we managed to expand our business with Volkswagen in these two years.”
On the execution side, the Porsche SuperVision system completed its first US-directed test: a 2,000 km expedition across urban, suburban, and highway roads in heavy snow. The vehicle used production EyeQ6 High SoC and ECU hardware with the latest software. Mobileye did not know the route in advance. Shashua called the system performance “outstanding” with “very few interventions” and framed it against competing demo systems that were part of the same expedition: “This shows that going from demo to production is an art and a science, and something that Mobileye excels in.”
Related: VW announced pre-series production of the ID. Buzz autonomous robotaxi at its Hanover facility, with vehicles coming off the regular assembly line. MOIA (the VW autonomy division) disclosed Orlando as the first launch city with BEEP, and LA testing is underway in collaboration with Uber. Path to commercialization: testing → commercial rides with safety driver → driver-out — all targeted for 2026 in the US. European scaling is targeted for 2027.
First-Ever Buyback — Framed Explicitly as Menti Dilution Offset
Mobileye announced its first-ever share repurchase program with the earnings release. Shashua’s framing is worth quoting directly because it is an implicit admission that the Menti deal looks worse in hindsight:
“While we continue to execute, we see an opportunity to deploy cash towards share repurchase, which will benefit all shareholders by partially offsetting dilution from stock-based compensation and addressing dilution from the Menti transaction at significantly more attractive prices than those embedded at closing.”
The Menti consideration was struck with embedded share prices around $14 in February 2026. At today’s $8.70, buying back shares does partially rebalance the dilution cost. The buyback is also the one capital-return tool that does not require Intel Class B approval, which matters for the minority shareholder governance concerns flagged in the Insider Investigator lens. Size and execution pace were not disclosed on the call; they will likely appear in the 10-Q.
Signal Changes
| Signal | Prior | Updated | Driver |
|---|---|---|---|
| REVENUE_DURABILITY | CONDITIONAL | IMPROVING | Beat + raise + Surround ADAS expansion |
| COMPETITIVE_POSITION | CONTESTED | DEFENSIBLE | VW reaffirmed, Porsche US test, US EV OEM win |
| CAPITAL_DEPLOYMENT | QUESTIONABLE | MIXED | First-ever buyback announced |
| NARRATIVE_REALITY_GAP | DIVERGING | NARROWING | Execution milestones replace promises |
FUNDING_FRAGILITY (STABLE), REGULATORY_EXPOSURE (MANAGEABLE), GOVERNANCE_ALIGNMENT (MIXED), and EXPECTATIONS_PRICED (MODEST) are unchanged. The posture shifted from PROCEED_WITH_CAUTION to STANDARD_DILIGENCE.
Forecast Markets: One Resolution, Seven Updates
One forecast market resolved YES: the Q1 2026 revenue question ("will revenue exceed $530M?") resolved at $558M actual. The ensemble predicted 72% YES at initial batch; Brier score 0.078. The other seven markets were updated with new probabilities:
| Market | Prior | Updated |
|---|---|---|
| FY2026 revenue >$2.0B | 35% | 42% |
| Top-10 OEM switches to NVIDIA/Qualcomm | 18% | 11% |
| Intel sells additional MBLY shares | 55% | 58% |
| Menti achieves tangible milestone | 42% | 48% |
| Porsche SuperVision SOP by Q2 2027 | 62% | 38% |
| China ADAS restrictions | 25% | 22% |
| FY2026 adj. op. margin >15% | 38% | 28% |
Two notable moves deserve attention. The Porsche SuperVision-by-Q2-2027 market dropped 24 points (62% to 38%) because Shashua explicitly guided the ramp to “2027 towards the second half of the year” — a push-out from the Q1 2027 timing implied at the Q4 2025 call. Technical execution risk declined (the 2,000 km US test went well) but the calendar reference moved. The FY adjusted operating margin market dropped because the guide implies 10.6% midpoint ($210M / $1.975B), well below the 15% threshold, dragged by lower-margin China OEM export mix and incremental ECU memory costs.
Want deeper analysis?
Read the full multi-lens equity analysis on Runchey Research.
Why Did the Stock Decline on Good News?
Between the prior analysis at $10.61 and today’s $8.70, the stock fell roughly 18% despite the operational improvement. Three partial explanations:
- Goodwill impairment optics — the $3.8B non-cash impairment likely hit the tape before most investors parsed the underlying mechanics. It is a consequence of the stock decline since the December 2025 annual test (market cap down ~35%) and a higher discount rate assumption. The CFO’s own framing: “On the business aspect, we kept the same projections but reflected a higher risk premium.” Business projections did not deteriorate. However, headline impairment numbers scare algorithmic traders and index screens.
- Porsche SOP push-out — the shift from Q1 2027 to H2 2027 for the marquee EyeQ6 launch is a real negative. The ensemble market probability moved accordingly.
- Intel overhang persistence — the ensemble still assigns 58% probability to additional Intel share sales. No news this quarter did not resolve the overhang.
Offsetting these: the buyback announcement provides technical support, the beat-and-raise confirms near-term execution, and valuation has compressed to ~3.5x revenue while fundamentals improved.
Thesis Reclassification: Undervalued
The combination of four signal upgrades, ensemble probability moves favorable across seven markets, a first-ever buyback, and an ~18% drawdown to ~3.5x revenue moves the thesis from price-at-value (at $10.61 in March) to undervalued (at $8.70 today). Confidence remains MEDIUM — the market’s reluctance to re-rate despite the beat-and-raise is itself information. It could signal unpriced concerns (Menti commercialization, Intel share sale risk, L4 timeline) that the ensemble is not fully capturing, or it could reflect slow recognition of the improved fundamentals. The next decisive data points are: Q2 earnings (H2 China export sustainability), the July 2026 AI Day (strategic clarity on Menti and AI roadmap), and robotaxi driver-out confirmation in H2 2026.